Download free PDF

Insulin Pump Market Size & Share 2024 – 2032

Market Size by Product [Devices (Tubed/tethered, Tubeless), Accessories (Battery, Insulin Reservoir or Cartridges, Insulin Set Insertion Devices)], End Use (Home Care, Hospitals & Clinics) – Global Forecast.

Report ID: GMI7983
   |
Published Date: January 2024
 | 
Report Format: PDF

Download Free PDF

Insulin Pump Market Size

Insulin Pump Market size was valued at over USD 5.2 billion in 2023 and is expected to witness 12.4% CAGR from 2024 to 2032, led by increasing collaborations with technology firms, research institutions, and healthcare providers to enhance device innovation. These partnerships are focused on integrating AI, improving patient data management, and developing advanced monitoring systems.

Insulin Pump Market Key Takeaways

Market Size & Growth

  • 2023 Market Size: USD 5.2 Billion
  • 2032 Forecast Market Size: USD 15 Billion
  • CAGR (2024–2032): 12.4%

Key Market Drivers

  • Rising prevalence of diabetes.
  • Technological advancements in insulin pumps.
  • Favourable device insurance and reimbursement policies.

Challenges

  • High cost of insulin pumps.
  • Stringent government regulations.

Furthermore, the expansion of these collaborations is leading to the inclusion of more personalized treatment options and real-time data analytics. These ventures are setting the stage for significant improvements in patient outcomes and the overall user experience. For instance, in May 2024, Xeris Biopharma Holdings and Beta Bionics collaborated to develop the world's first dual-hormone pump. This innovative device enables to manage both low and high blood sugar levels more effectively.
 

 The prevalence of diabetes is increasing globally and leading to the higher demand for advanced management tools. To that end, insulin pumps have grown popular as they are evolving to offer better glucose control, convenience, and integration with other diabetes technologies. These devices are streamlining the process of insulin delivery by providing continuous subcutaneous infusion, further helping patients to maintain stable blood glucose levels.
 

Moreover, insulin pumps are incorporated with more advanced features, including AI and real-time monitoring to further enhance the quality of life for people with diabetes. For instance, the International Diabetes Federation reported that the prevalence of diabetes globally is expected to rise to 783 million by 2045. This growing target population will boost the product demand.
 

However, the high cost of insulin pump therapy is limiting its accessibility and exacerbating the risk of hypoglycemia and hyperglycemia. Manufacturers are working on reducing production costs and improving insurance coverage to address these barriers. However, advancements in technology and healthcare policies will continue to mitigate these challenges for ensuring more equitable access to the therapies.
 

Insulin Pump Market

Insulin Pump Market Trends

Technological advancements in insulin pumps are transforming diabetes management. Engineers are developing smaller, more discreet pumps with improved accuracy and connectivity features. These pumps are used for continuously monitoring glucose levels and adjusting insulin delivery in real-time for providing users with greater control and flexibility. In addition, researchers are integrating cutting-edge technologies into insulin pump systems for enabling predictive algorithms to anticipate glucose fluctuations and prevent hypoglycemia or hyperglycemia before they occur. This ongoing innovation will enhance the quality of life for individuals living with diabetes by offering more personalized and proactive treatment solutions.
 

For instance, in May 2023, the FDA cleared a new insulin pump along with algorithm-based software for facilitating enhanced automatic insulin delivery. This development marked a significant step forward in diabetes management to offer improved precision and convenience for patients.
 

Insulin Pump Market Analysis

Insulin Pump Market, By Product, 2021 - 2032 (USD Billion)

On the basis of product, the market size from the devices segment is projected to reach over USD 12.5 billion by 2032. Insulin pump devices are undergoing continuous advances to cater to the evolving requirements of diabetes management. Manufacturers are integrating features, such as real-time glucose monitoring and smartphone connectivity for enhancing user experience and control. Subsequently, these devices are preferred as they leverage emerging technologies like machine learning and sensor miniaturization. This development will enable more precise insulin delivery tailored to individual needs for ensuring better glucose control and minimizing the risk of complications, thus transforming diabetes care on a global scale.
 

Insulin Pump Market, By End-use (2023)

In terms of end-use, the insulin pump industry from the home care segment is expected to record 12.7% CAGR through 2032, due to increasing usage at homes for providing patients with greater autonomy in managing their diabetes. Individuals are incorporating these pumps into their daily routines for benefiting from continuous glucose monitoring and remote monitoring capabilities. Furthermore, advancements in telemedicine and wearable technology are enabling even more seamless integration into the lives of patients. This ongoing evolution will empower individuals to take charge of their health more effectively for fostering greater independence and improving overall quality of life for those managing diabetes at home.
 

North America Insulin Pump Market, 2020- 2032 (USD Billion)

North America insulin pump market is predicted to record over USD 6 billion by 2032 due to the rising geriatric population and supportive reimbursement policies. Healthcare providers are increasingly recommending insulin pump therapy for elderly patients across the region. Reimbursement policies are being updated to cover a larger portion of pump costs for making these devices more accessible to patients. Furthermore, the  increasing development of more advanced and user-friendly insulin pump technologies tailored to meet the unique needs of elderly diabetes patients will favor the regional industry growth.
 

Insulin Pump Market Share

These players are innovating their products and services to stay competitive. They are expanding their global reach through strategic partnerships and acquisitions. In addition, these companies are diversifying their offerings and exploring emerging markets to sustain growth and meet the evolving patient needs.
 

Insulin Pump Market Companies

Some of the major insulin pump industry contenders are:

  • Debiotech S.A.
  • F. Hoffmann La
  • Insulet Corporation
  • Lenomed Medical
  • Nipro Corporation
  • Medtronic plc
  • Roche AG
  • MicroPort
  • Scientific Corporation
  • Tandem Diabetic Care Inc.
  • Terumo Corporation
  • ViCentra B.V.
  • Ypsomed
     

Insulin Pump Industry News

  • In January 2024, Abbott and Tandem Diabetes Care, Inc. unveiled the compatibility of the tX2 insulin pump with Control-IQ technology with Abbott's latest continuous glucose monitoring (CGM) tech, the FreeStyle Libre 2 Plus sensor. This marked the debut of a hybrid closed-loop system for FreeStyle Libre users in the U.S. for predicting and averting high and low blood sugar levels.
     
  • In April 2023, Medtronic plc announced the FDA approval of the MiniMed 780G system with the Guardian 4 sensor, featuring SmartGuard technology for eliminating the need for fingersticks. This innovation automatically administers insulin to counter instances of bolus neglect or carbohydrate overestimation.
     

Insulin pump market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:

Market, By Product

  • Devices
    • Tubed/tethered
    • Tubeless
  • Accessories
    • Battery
    • Insulin reservoir or cartridges
    • Insulin set insertion devices

Market, By End-use

  • Home care
  • Hospitals & clinics
  • Other end-users

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • UAE
    • Rest of Middle East and Africa

 

Authors:  Mariam Faizullabhoy, Gauri Wani

Research methodology, data sources & validation process

This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.

Our 6-step research process

  1. 1. Research design & analyst oversight

    At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.

    Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.

  2. 2. Primary research

    Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.

  3. 3. Data mining & market analysis

    Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.

  4. 4. Market sizing

    Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.

  5. 5. Forecast model & key assumptions

    Every forecast includes explicit documentation of:

    • ✓ Key growth drivers and their assumed impact

    • ✓ Restraining factors and mitigation scenarios

    • ✓ Regulatory assumptions and policy change risk

    • ✓ Technology adoption curve parameter

    • ✓ Macroeconomic assumptions (GDP growth, inflation, currency)

    • ✓ Competitive dynamics and market entry/exit expectations

  6. 6. Validation & quality assurance

    The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.

    Our triple-layer validation process ensures maximum data reliability:

    • ✓ Statistical Validation

    • ✓ Expert Validation

    • ✓ Market Reality Check

Trust & credibility

10+
Years in Service
Consistent delivery since establishment
A+
BBB Accreditation
Professional standards & satisfaction
ISO
Certified Quality
ISO 9001-2015 Certified Company
150+
Research Analysts
Across 10+ industry verticals
95%
Client Retention
5-year relationship value

Verified data sources

  • Trade publications

    Security & defense sector journals and trade press

  • Industry databases

    Proprietary and third-party market databases

  • Regulatory filings

    Government procurement records and policy documents

  • Academic research

    University studies and specialist institution reports

  • Company reports

    Annual reports, investor presentations, and filings

  • Expert interviews

    C-suite, procurement leads, and technical specialists

  • GMI archive

    13,000+ published studies across 30+ industry verticals

  • Trade data

    Import/export volumes, HS codes, and customs records

Parameters studied & evaluated

Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →

Frequently Asked Question(FAQ) :
How much is the insulin pump industry worth?
The insulin pump market size was valued at over USD 5.2 billion in 2023 and is expected to witness 12.4% CAGR from 2024 to 2032, led by increasing collaborations with technology firms, research institutions, and healthcare providers to enhance device innovation.
Why is the demand for insulin pump rising in home care?
The home care segment of market held a robust growth in 2023 and is expected to record 12.7% CAGR through 2032, due to increasing usage at homes for providing patients with greater autonomy in managing their diabetes.
Why is the insulin pump industry booming in North America?
North America insulin pump market held a decent market share in 2023 and is predicted to record over USD 6 billion by 2032, due to the rising geriatric population and supportive reimbursement policies.
Who are the major insulin pump industry players?
Debiotech S.A., F. Hoffmann La, Insulet Corporation, Lenomed Medical, Nipro Corporation, Medtronic plc, Roche AG, MicroPort , Scientific Corporation among others.
Insulin Pump Market Scope
  • Insulin Pump Market Size

  • Insulin Pump Market Trends

  • Insulin Pump Market Analysis

  • Insulin Pump Market Share

Authors:  Mariam Faizullabhoy, Gauri Wani
Explore Our Licensing Options:

Starting at: $2,450

Premium Report Details:

Base Year: 2023

Companies Profiled: 11

Tables & Figures: 255

Countries Covered: 22

Pages: 120

Download Free PDF

We use cookies to enhance user experience. (Privacy Policy)